Bogner, Balázs
Jung, Matthias
Reisert, Marco
Maushagen, Juliane
Rospleszcz, Susanne
Kroencke, Thomas
Pischon, Tobias
Schulz-Menger, Jeanette
Niendorf, Thoralf
Völzke, Henry
Schlett, Christopher L.
Bamberg, Fabian
Taron, Jana
Weiss, Jakob
Funding for this research was provided by:
Universitätsklinikum Freiburg
Article History
Received: 10 April 2026
Accepted: 14 June 2026
First Online: 1 July 2026
Declarations
:
: This study was conducted under the UKB’s general ethical approval from the NHS National Research Ethics Service. All UKB participants provided written informed consent at enrollment. Informed consent was also obtained from all participants in the NAKO. In addition, local IRB approval was received from the University of Freiburg (IRB numbers: 23–1316-S1-retro and 24–1099-S1-retro).
: Not applicable.
: CLS: Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events: Siemens Healthineers, Bayer Healthcare. FB: Grants or contracts from any entity: Siemens Healthineers, Bayer Healthcare. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Siemens Healthineers, Bayer Healthcare. JT: Consulting fees: Onc.AI. JW: Consulting fees: Onc.AI.